TY - JOUR T1 - For a structured response to the psychosocial consequences of the restrictive measures imposed by the global COVID-19 health pandemic: The MAVIPAN longitudinal prospective cohort study protocol JF - medRxiv DO - 10.1101/2020.11.10.20227397 SP - 2020.11.10.20227397 AU - Annie LeBlanc AU - Marie Baron AU - Patrick Blouin AU - George Tarabulsy AU - François Routhier AU - Catherine Mercier AU - Jean-Pierre Després AU - Marc Hébert AU - Yves De Koninck AU - Caroline Cellard AU - Delphine Collin-Vézina AU - Nancy Côté AU - Marie-Pier Déry AU - Émilie Dionne AU - Richard Fleet AU - Marie-Hélène Gagné AU - Maripier Isabelle AU - Lily Lessard AU - Matthew Menear AU - Chantal Mérette AU - Marie-Christine Ouellet AU - Marc-André Roy AU - Marie-Christine Saint-Jacques AU - Claudia Savard AU - on behalf of the MAVIPAN Research Collaboration Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/01/17/2020.11.10.20227397.abstract N2 - Background The COVID-19 pandemic and the isolation measures taken to control it has caused important disruptions in economies and labour markets, changed the way we work and socialize, forced schools to close and healthcare and social services to reorganize in order to redirect resources on the pandemic response. This unprecedented crisis forces individuals to make considerable efforts to adapt and can have serious psychological and social consequences that are likely to persist once the pandemic has been contained and restrictive measures lifted. These impacts will be significant for vulnerable individuals and will most likely exacerbate existing social and gender health and social inequalities. This crisis also puts a toll on the capacity of our healthcare and social services structures to provide timely and adequate care. In order to minimize these consequences, there is an urgent need for high-quality, real-time information on the psychosocial impacts of the pandemic. The MAVIPAN (Ma vie et la pandémie/My life with the pandemic) study aims to document how individuals, families, healthcare workers, and health organisations that provide services are affected by the pandemic and how they adapt.Methods The MAVIPAN study is a 5-year longitudinal prospective cohort study that was launched on April 29th, 2020 in the province of Quebec which, at that time, was the epicenter of the pandemic in Canada. Quantitative data is collected through online questionnaires approximately 5 times a year depending on the pandemic evolution. Questionnaires include measures of health, social, behavioral and individual determinants as well as psychosocial impacts. Qualitative data will be collected with individual and group interviews that seek to deepen our understanding of coping strategies.Discussion The MAVIPAN study will support the healthcare and social services system response by providing the evidence base needed to identify those who are most affected by the pandemic and by guiding public health authorities’ decision making regarding intervention and resource allocation to mitigate these impacts. It is also a unique opportunity to advance our knowledge on coping mechanisms and adjustment strategies.Trial registration NCT04575571 (retrospectively registered)Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04575571. This study was registered retrospectively. Considering the very short timeframe and the urgency surrounding the pandemic as well as the fact that registering observational studies is not mandatory, the priority was given to the implementation of this project before registering it.Funding StatementFunding for this study comes from discretionary funds from the four Research Centers of the Quebec Integrated University Health and Social Services Center (CIUSSS de la Capitale Nationale).(Vitam: Centre de recherche en santé durable, Centre de recherche universitaire sur les jeunes et les familles (CRUJeF), Centre interdisciplinaire de recherche en réadaptation et intégration sociale (CIRRIS), Centre de recherche CERVO).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is approved by the Ethics Committee of the Primary Care and Population Health Research Sector of the CIUSSS de la Capitale-Nationale (Reference number: 2021-2043).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesN/A ER -